YATSUDA JUNJI 矢津田旬二

… Alternative Names

Yatsuda Junji 矢津田旬二

Less

Researcher Number	20749626
Other IDs
Affiliation (Current)	2025: 熊本大学, 大学院生命科学研究部(医), 講師
Affiliation (based on the past Project Information) *help	2024: 熊本大学, 大学院生命科学研究部(医), 講師 2020 – 2022: 熊本大学, 大学院生命科学研究部(医), 講師 2018 – 2019: 熊本大学, 大学院生命科学研究部(医), 助教
Review Section/Research Field	Principal Investigator Basic Section 56030:Urology-related Except Principal Investigator Basic Section 56030:Urology-related
Keywords	Principal Investigator CD169 / マクロファージ / 腫瘍免疫 / 抗原提示 / がん免疫療法 / CD8陽性リンパ球 / CD169陽性リンパ洞性マクロファージ / 免疫チェックポイント阻害剤 / ナリンジン Except Principal Investigator 腎細胞癌 … More / 腎癌 / 免疫抑制 / 尿路上皮癌 / 免疫抑制機構 / 複合免疫療法 / サイトフ / マスサイトメトリー / 腎癌薬物療法 / 腫瘍免疫 / 免疫チェックポイント阻害薬 / Cytof / 免疫関連副作用 / 免疫療法 / ３次元培養 / 質量分析 / 3次元培養 / 新規標的分子 / VHL Less

Analysis of lymph node antigen-presenting cells and regulation of their activation; toward development of novel cancer immunotherapyPrincipal Investigator
- Principal Investigator
  
  矢津田旬二
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Kumamoto University
Integrated Analysis of Intratumoral and Systemic Immune Environment in Renal Cell Carcinoma and Urothelial Carcinoma
- Principal Investigator
  
  Motoshima Takanobu
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Kumamoto University
Development of new cancer immunotherapy focusing on lymph node antigen-presenting cellsPrincipal Investigator
- Principal Investigator
  
  Yatsuda Junji
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Kumamoto University
Exploring novel downstream targets of VBC-Cul2 complex in clear cell renal cell carcinoma
- Principal Investigator
  
  Kamba Tomomi
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Kumamoto University

All 2023 2022 2021 2020

All Journal Article Presentation

[Journal Article] Predictive value of CXCL10 for the occurrence of immune‐related adverse events in patient with renal cell carcinoma2023
- Author(s)
  Miura Yuji、Motoshima Takanobu、Anami Toshiki、Yano Hiromu、Mito Remi、Pan Cheng、Urakami Shinji、Kinowaki Keiichi、Tsukamoto Hirotake、Kurahashi Ryoma、Murakami Yoji、Yatsuda Junji、Fujiwara Yukio、Kamba Tomomi、Komohara Yoshihiro
- Journal Title
  
  Microbiology and Immunology
  
  Volume: Online ahead of print. Issue: 7 Pages: 345-354
- DOI
  10.1111/1348-0421.13067
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K09560, KAKENHI-PROJECT-23K06362, KAKENHI-PROJECT-20K07669, KAKENHI-PROJECT-20K16450, KAKENHI-PROJECT-21H02788
[Journal Article] Subcapsular renal hematoma after ureterorenoscopy2022
- Author(s)
  Harada Narumi、Yatsuda Junji、Kurahashi Ryoma、Fukushima Yumi、Segawa Takuya、Motoshima Takanobu、Murakami Yoji、Yamaguchi Takahiro、Sugiyama Yutaka、Kamba Tomomi
- Journal Title
  
  IJU Case Reports
  
  Volume: 5 Issue: 4 Pages: 281-285
- DOI
  10.1002/iju5.12464
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K09560
[Journal Article] Clear cell carcinoma of the seminal vesicle in a young adult2022
- Author(s)
  Murakami Hidetoshi、Motoshima Takanobu、Kurahashi Ryoma、Murakami Yoji、Sugiyama Yutaka、Yamaguchi Takahiro、Yatsuda Junji、Asato Tsuguharu、Mikami Yoshiki、Kamba Tomomi
- Journal Title
  
  IJU Case Reports
  
  Volume: 5 Issue: 5 Pages: 406-409
- DOI
  10.1002/iju5.12502
- Data Source
  KAKENHI-PROJECT-20K09560
[Journal Article] Efficacy of avelumab plus axitinib for advanced renal cell carcinoma as late-line therapy: A case report2022
- Author(s)
  Uekawa Ayano、Kurahashi Ryoma、Motoshima Takanobu、Murakami Yoji、Yatsuda Junji、Kamba Tomomi
- Journal Title
  
  Urology Case Reports
  
  Volume: 45 Pages: 102198-102198
- DOI
  10.1016/j.eucr.2022.102198
- Data Source
  KAKENHI-PROJECT-20K09560
[Journal Article] High T-cell infiltration in tumor tissue and younger age predict the response to pembrolizumab in recurrent urothelial cancer2021
- Author(s)
  Anami, Toshiki Komohara, Yoshihiro Miura, Yuji Yamanaka, Kotaro Kurahashi, Ryoma Segawa, Takuya Motoshima, Takanobu Murakami, Yoji Yatsuda, Junji Yamaguchi, Takahiro Sugiyama, Yutaka Jinnouchi, Yoshiteru Kamba, Tomomi
- Journal Title
  
  Med Mol Morphol
  
  Volume: 54 Issue: 4 Pages: 316-323
- DOI
  10.1007/s00795-021-00292-8
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K09560
[Journal Article] HLA-DR and CD74 Expression and the Immune Microenvironment in Renal Cell Carcinoma2021
- Author(s)
  Miura, Y. Anami, T. Yatsuda, J. Motoshima, T. Oka, S. Suyama, K. Inoshita, N. Kinowaki, K. Urakami, S. Kamba, T. Komohara, Y.
- Journal Title
  
  Anticancer Res
  
  Volume: 41 Issue: 6 Pages: 2841-2848
- DOI
  10.21873/anticanres.15065
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K09560
[Journal Article] Remarkable antitumor effect of nivolumab in a patient with metastatic renal cell carcinoma previously treated with a peptide‐based vaccine2020
- Author(s)
  Kurahashi Ryoma、Motoshima Takanobu、Fukushima Yumi、Murakami Yoji、Yatsuda Junji、Yamaguchi Takahiro、Sugiyama Yutaka、Fukushima Satoshi、Komohara Yoshihiro、Suekane Shigetaka、Kamba Tomomi
- Journal Title
  
  IJU Case Reports
  
  Volume: 3 Issue: 2 Pages: 44-48
- DOI
  10.1002/iju5.12139
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K09182, KAKENHI-PROJECT-20K09560
[Presentation] 免疫チェックポイント阻害薬投与後に腎摘除術を行った2例2022
- Author(s)
  元島　崇信、倉橋　竜磨、矢津田　旬二、村上　洋嗣、脊川　卓也、杉山　豊、神波　大己
- Organizer
  第52回腎癌研究会
- Data Source
  KAKENHI-PROJECT-20K09560
[Presentation] 熊本大学病院における1st line Ipi-Nivo2022
- Author(s)
  元島　崇信、背川　卓也、倉橋　竜磨、村上　洋嗣、矢津田　旬二、杉山　豊、神波　大己
- Organizer
  第60回日本癌治療学会
- Data Source
  KAKENHI-PROJECT-20K09560
[Presentation] Antitumor effect of naringin, a natural compound, via activating CD169-positive macrophages in lymph nodes2022
- Author(s)
  shiki Anami, Yukio Fujiwara, Cheng Pan, Takanobu Motoshima, Junji Yatsuda, Yoshihiro Komohara, Tomomi Kamba
- Organizer
  日本癌学会
- Data Source
  KAKENHI-PROJECT-20K09579
[Presentation] RAPNを施行して好酸性乳頭状腎細胞癌と診断された2例2022
- Author(s)
  元島崇信、原田成美、石﨑宏志、野尻拓矢、倉橋竜磨、福島結美脊川卓也、村上洋嗣、矢津田旬二、山口隆大、杉山豊、神波大己
- Organizer
  第10回日本泌尿器病理研究会学術集会
- Data Source
  KAKENHI-PROJECT-20K09560
[Presentation] 生検で尿路上皮癌由来の癌肉腫と診断され、ペンブロリズマブが著効した嫌色素性腎細胞癌由来の癌肉腫の1例2021
- Author(s)
  元島崇信、野尻拓矢、倉橋竜磨、村上洋嗣、矢津田旬二、山口隆大、杉山豊、川上史、三上芳喜、神波大己
- Organizer
  第19回日本臨床腫瘍学会
- Data Source
  KAKENHI-PROJECT-20K09560
[Presentation] 10次治療にカボザンチニブを導入して腫瘍縮小効果を示した進行性腎細胞癌の一例2021
- Author(s)
  元島　崇信、背川　卓也、倉橋　竜磨、村上　洋嗣、矢津田　旬二、杉山　豊、山口　隆大、神波　大己
- Organizer
  第7回日本泌尿器腫瘍学会
- Data Source
  KAKENHI-PROJECT-20K09560
[Presentation] 熊本大学病院におけるかん複合免疫療法の治療効果と副作用の発現2021
- Author(s)
  元島　崇信、背川　卓也、倉橋　竜磨、村上　洋嗣、矢津田　旬二、杉山　豊、山口　隆大、西　一彦、神波　大己
- Organizer
  第59回日本がん治療学会
- Data Source
  KAKENHI-PROJECT-20K09560
[Presentation] 高齢女性に発症した転移性腎原発性神経内分泌腫瘍の一例2020
- Author(s)
  元島　崇信, 倉橋　竜磨, 村上　洋嗣, 矢津田　旬二, 山口　隆大, 杉山　豊, 神波　大己
- Organizer
  第9回日本泌尿器病理研究会
- Data Source
  KAKENHI-PROJECT-20K09560
[Presentation] 熊本大学病院におけるニボルマブとイピリムマブ併用療法の経験2020
- Author(s)
  元島　崇信、山中　広太郎、倉橋　竜磨、村上　洋嗣、矢津田　旬二、杉山　豊、山口　隆大、西　一彦、神波　大己
- Organizer
  第58回日本癌治療学会学術集会
- Data Source
  KAKENHI-PROJECT-20K09560
[Presentation] 熊本大学における分子標的薬の進行性腎癌に対する治療成績の検討2020
- Author(s)
  元島　崇信、穴見　俊樹、山中　広太郎、倉橋　竜磨、村上　洋嗣、矢津田　旬二、山口　隆大、杉山　豊、西　一彦、神波　大己
- Organizer
  第108回日本泌尿器科学会総会
- Data Source
  KAKENHI-PROJECT-20K09560

1. Kamba Tomomi (20402836)

# of Collaborated Projects: 4 results

# of Collaborated Products: 16 results
2. Motoshima Takanobu (60726355)

# of Collaborated Projects: 4 results

# of Collaborated Products: 16 results
3. 村上洋嗣 (70735703)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
4. 菰原義弘 (40449921)

# of Collaborated Projects: 3 results

# of Collaborated Products: 4 results
5. 倉橋竜磨 (80867945)

# of Collaborated Projects: 3 results

# of Collaborated Products: 14 results
6. 馬場理也 (10347304)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
7. 杉山豊 (40709292)

# of Collaborated Projects: 2 results

# of Collaborated Products: 9 results
8. 荒木令江 (80253722)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 三浦裕司 (10453698)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
10. 新留琢郎 (20264210)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 末金茂高

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

YATSUDA JUNJI 矢津田 旬二

Yatsuda Junji 矢津田 旬二

Research Projects

Research Products

Co-Researchers

Analysis of lymph node antigen-presenting cells and regulation of their activation; toward development of novel cancer immunotherapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Integrated Analysis of Intratumoral and Systemic Immune Environment in Renal Cell Carcinoma and Urothelial Carcinoma

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of new cancer immunotherapy focusing on lymph node antigen-presenting cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Exploring novel downstream targets of VBC-Cul2 complex in clear cell renal cell carcinoma

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Predictive value of CXCL10 for the occurrence of immune‐related adverse events in patient with renal cell carcinoma2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Subcapsular renal hematoma after ureterorenoscopy2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clear cell carcinoma of the seminal vesicle in a young adult2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Efficacy of avelumab plus axitinib for advanced renal cell carcinoma as late-line therapy: A case report2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] High T-cell infiltration in tumor tissue and younger age predict the response to pembrolizumab in recurrent urothelial cancer2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] HLA-DR and CD74 Expression and the Immune Microenvironment in Renal Cell Carcinoma2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Remarkable antitumor effect of nivolumab in a patient with metastatic renal cell carcinoma previously treated with a peptide‐based vaccine2020

Author(s)

Journal Title

DOI

Data Source

[Presentation] 免疫チェックポイント阻害薬投与後に腎摘除術を行った2例2022

Author(s)

Organizer

Data Source

[Presentation] 熊本大学病院における1st line Ipi-Nivo2022

Author(s)

Organizer

Data Source

[Presentation] Antitumor effect of naringin, a natural compound, via activating CD169-positive macrophages in lymph nodes2022

Author(s)

Organizer

Data Source

[Presentation] RAPNを施行して好酸性乳頭状腎細胞癌と診断された2例2022

Author(s)

Organizer

Data Source

YATSUDA JUNJI 矢津田旬二

Yatsuda Junji 矢津田旬二

[Presentation] 生検で尿路上皮癌由来の癌肉腫と診断され、ペンブロリズマブが著効した嫌色素性腎細胞癌由来の癌肉腫の1例2021